No increased mortality in patients with rheumatoid arthritis treated with biologics: results from the biologics register of six rheumatology institutes in Japan

Author： Nakajima Ayako   Saito Kazuyoshi   Kojima Toshihisa   Amano Koichi   Yoshio Taku   Fukuda Wataru   Inoue Eisuke   Taniguchi Atsuo   Momohara Shigeki   Minota Seiji   Takeuchi Tsutomu   Ishiguro Naoki   Tanaka Yoshiya   Yamanaka Hisashi  

Publisher： Springer Publishing Company

ISSN： 1439-7595

Source： Modern Rheumatology, Vol.23, Iss.5, 2013-09, pp. : 945-952

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inflammatory immune cell responses and Toll-like receptor expression in synovial tissues in rheumatoid arthritis patients treated with biologics or DMARDs

By Takakubo Yuya  

Clinical Rheumatology, Vol. 32, Iss. 6, 2013-06 ,pp. : 853-861

Springer Publishing Company

Access to resources Recommend Favorite

A review of tocilizumab treatment in 122 rheumatoid arthritis patients included in the Tsurumai Biologics Communication Registry (TBCR) Study

By Yabe Yuichiro  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 245-253

Springer Publishing Company

Access to resources Recommend Favorite

Clinical evaluation of tocilizumab for patients with active rheumatoid arthritis refractory to anti-TNF biologics: tocilizumab in combination with methotrexate

By Nakashima Yasuharu   Kondo Masakazu   Harada Hiroshi   Horiuchi Takahiko   Ishinishi Takashi   Jojima Hiroshi   Kuroda Koji   Miyahara Hisaaki   Nagamine Ryuji   Nakashima Hitoshi   Otsuka Takeshi   Saikawa Isao   Shono Eisuke   Suematsu Eiichi   Tsuru Tomomi   Wada Ken   Iwamoto Yukihide  

Modern Rheumatology, Vol. 20, Iss. 4, 2010-08 ,pp. : 343-352

Springer Publishing Company

Access to resources Recommend Favorite

Impact of Traditional Therapies and Biologics on Cardiovascular Diseases in Rheumatoid Arthritis

By  

Current Vascular Pharmacology, Vol. 6, Iss. 3, 2008-07 ,pp. : 218-227

Bentham Science Publishers

Access to resources Recommend Favorite

A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology

By Takamura Akito  

Modern Rheumatology, Vol. 23, Iss. 2, 2013-03 ,pp. : 297-303

Springer Publishing Company

Access to resources Recommend Favorite